No Supply Issues With Ivermectin: Pharmaceutical Supplying PRINCIPLE Oxford Trial

The New Jersey pharmaceutical company supplying ivermectin to a UK trial that was paused for a short period of time, says there are no supply issues with its pills.
Ivermectin is being investigated as part of the government-backed Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE) in the United Kingdom as a possible home treatment for COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. The trial was put on hold due to “temporary supply issues” as reported by Medpage Today on Dec. 14.
Details were not provided on the cause of the supply issues. The trial’s joint chief investigator, professor Chris Butler, and the trial’s press team declined to comment and respond to a query asking when the supply issue is expected to be resolved.
The events of the past five or six years have demonstrated to America that the FBI is no longer the unbiased law enforcement agency it once was. Between the Hillary Clinton investigation-in-name-only, the Crossfire Hurricane hoax, the targeting of Americans as domestic terrorists, and playing three blind mice with the Biden graft machine, the bureau’s issues can’t be ignored any longer. If we don’t take corrective action soon, the FBI will finish its transition from law enforcement to being a political functionary advancing the interests of one party.






